Adaptimmune Therapeutics plc Made Big Gain
Tue, Nov 08, 2022 at 07:54 PM
Adaptimmune Therapeutics plc (ADAP:NASDAQ) shot up at $2.08, representing a gain of 25.3%. On Tue, Nov 08, 2022, ADAP:NASDAQ touched a New 2-Week High of $2.08. The stock got featured on our News Catalysts scanner on Tue, Nov 08, 2022 at 07:49 AM in the 'BIOTECH' category. From Tue, Oct 25, 2022, the stock recorded 100.00% Up Days and 90.91% Green Days
About Adaptimmune Therapeutics plc (ADAP:NASDAQ)
Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.
Top 10 Gainers:
- Renovare Environmental Inc. (RENO:NASDAQ), 60%
- Unique Fabricating, Inc. (UFAB:NYSEMKT), 56.26%
- Bull Horn Holdings Corp. (BHSE:NASDAQ), 44.67%
- TaskUs Inc. (TASK:NASDAQ), 37.22%
- SkyWater Technology Inc. (SKYT:NASDAQ), 31.6%
- Groupon, Inc. (GRPN:NASDAQ), 27.41%
- Oportun Financial Corporation (OPRT:NASDAQ), 26.75%
- National CineMedia, Inc. (NCMI:NASDAQ), 26.15%
- NeoGenomics, Inc. (NEO:NASDAQ), 25.35%
- Adaptimmune Therapeutics plc (ADAP:NASDAQ), 25.3%